Post Marketing Surveillance Study of Cuprimine
1 other identifier
expanded_access
N/A
0 countries
N/A
Brief Summary
Cuprimine (penicillamine) was made available in the Philippines by the Sponsor under a Compassionate Special Permit issued by the Bureau of Food and Drugs. Physicians were able to request the drug for their patients from the Sponsor. A Clinical Study Report form was completed for each purchase of Cuprimine.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2011
CompletedFirst Posted
Study publicly available on registry
June 15, 2011
CompletedOctober 22, 2015
October 1, 2015
June 14, 2011
October 21, 2015
Conditions
Interventions
Dosage determined by the physician based on indication for treatment
Eligibility Criteria
You may qualify if:
- \- None
You may not qualify if:
- \- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- expanded access
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 14, 2011
First Posted
June 15, 2011
Last Updated
October 22, 2015
Record last verified: 2015-10